A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT07081958 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity or Overweight

Interventions

DRUG: RO7795081
DRUG: Placebo

Sponsor

Hoffmann-La Roche